NPPA fixes prices of 50 FDC drugs and revises 4 others
New Delhi:Prices of 50 Drugs have been fixed, while 4 others revised, by the National Pharmaceutical Pricing Authority (NPPA). This is part of the new drug pricing control order, notified on March 14, which effectively brings 200 more drug formulations under regulation.
40 other drugs are to be priced by the NPPA in the coming weeks, for which the NPPA has asked requisite information be provided to it, by the companies. 92 applications for evaluation are up with the NPPA for retail price fixation of new fixed dose combinations (FDC's), the authority informed the parliament on Friday, reports Business Standard.
The NPPA has issued directions to all pharmaceutical companies with pending FDC applications to submit signed declarations by designated authority that the FDC's put up by them have not been banned by the drug control authorities.
"At present, 92 applications for retail price fixation of new FDCs are under examination at NPPA," Minister of State for Chemicals and Fertilisers Hansraj Gangaram Ahir said in a written reply to the Rajya Sabha.
40 other drugs are to be priced by the NPPA in the coming weeks, for which the NPPA has asked requisite information be provided to it, by the companies. 92 applications for evaluation are up with the NPPA for retail price fixation of new fixed dose combinations (FDC's), the authority informed the parliament on Friday, reports Business Standard.
The NPPA has issued directions to all pharmaceutical companies with pending FDC applications to submit signed declarations by designated authority that the FDC's put up by them have not been banned by the drug control authorities.
"At present, 92 applications for retail price fixation of new FDCs are under examination at NPPA," Minister of State for Chemicals and Fertilisers Hansraj Gangaram Ahir said in a written reply to the Rajya Sabha.
FDCfixed dose combinationsHansraj Gangaram AhirMinister of State for Chemicals and FertilisersHansraj Gangaram AhirNational Pharmaceutical Pricing AuthorityNPPA
Source : Inputs from Business StandardsNext Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd